| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/04/2000 | US6011139 Polypeptides |
| 01/04/2000 | US6010682 Liposoluble compounds useful as magnetic resonance imaging agents |
| 01/04/2000 | US6010681 Biodegradable blood-pool contrast agents |
| 12/29/1999 | WO1999067284A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 12/29/1999 | WO1999067248A1 Carotene analog of porhyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents |
| 12/29/1999 | WO1999066951A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | WO1999066916A1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 12/29/1999 | WO1999066840A1 Improvements in or relating to cardiac imaging |
| 12/29/1999 | WO1999066831A2 Utilization of 5-aminolevulinic acid or a derivative thereof for photodynamic diagnosis or photodynamic therapy of diseases of the parodontium and teeth |
| 12/29/1999 | WO1999055670A3 Imidazol-like products and derivatives |
| 12/29/1999 | EP0967491A2 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
| 12/29/1999 | EP0967277A2 Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 12/29/1999 | EP0966975A2 Diagnostic agents for pancreatic exocrine function |
| 12/29/1999 | EP0966537A2 AN $i(EX VIVO) ANIMAL OR CHALLENGE MODEL AS METHOD TO MEASURE PROTECTIVE IMMUNITY DIRECTED AGAINST PARASITES AND VACCINES SHOWN TO BE PROTECTIVE IN SAID METHOD |
| 12/29/1999 | EP0966428A1 PROCESS FOR THE CRYSTALLIZATION FROM A LINEAR OR BRANCHED (C5-C6) ALCOHOL OR THEIR MIXTURES OF (S)-N,N'-bis 2-HYDROXY-1- (HYDROXYMETHYL)ETHYL]-5- (2-HYDROXY-1-OXOPROPYl)AMINO]-2,4,6- TRIIODO-1,3-BENZENDICARBOXAMIDE |
| 12/29/1999 | EP0966427A1 Preparation of acid amides and metallisation of compounds |
| 12/29/1999 | EP0966414A1 Triarylmethyl free radicals as image enhancing agents |
| 12/29/1999 | EP0966306A1 Method of measuring physiological function |
| 12/29/1999 | EP0966305A1 Contrast agents containing two types of gas filled microbubbles |
| 12/29/1999 | EP0769969A4 Gas-filled microspheres with fluorine-containing shells |
| 12/29/1999 | CN1239958A Macrocyclic metal complex carboxylic acids, use and method for production thereof |
| 12/29/1999 | CN1239884A Porous microcapsules and their use as therapeutic and diagnostic vehicles |
| 12/29/1999 | CN1239676A Bowel movement simulating contrast medium |
| 12/29/1999 | CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | CA2336095A1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 12/29/1999 | CA2336052A1 Improvements in or relating to cardiac imaging |
| 12/29/1999 | CA2331763A1 Carotene analog of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents |
| 12/29/1999 | CA2328457A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 12/28/1999 | US6008435 Detecting cow, sheep and human prions in a sample and transgenic mice used for same |
| 12/28/1999 | US6007691 For conveniently diagnosing various physiological conditions that produce altered levels of specific carbohydrates, known as diagnostic carbohydrates |
| 12/23/1999 | WO1999066255A2 Resilient containers for hyperpolarized gases |
| 12/23/1999 | WO1999066254A1 Hyperpolarized gas transport device and associated transport method |
| 12/23/1999 | WO1999066036A1 Transplants for myocardial scars |
| 12/23/1999 | WO1999065508A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 12/23/1999 | WO1999065467A1 Method for introducing a chemical agent into the systemic circulation |
| 12/23/1999 | DE19827417A1 New material for differentially modifying the optical activities of different cells comprises a mixture of a base material and a modification material |
| 12/23/1999 | CA2637700A1 Resilient containers for hyperpolarized gases |
| 12/23/1999 | CA2335248A1 Transplants for myocardial scars |
| 12/22/1999 | EP0964705A1 Testkit and method |
| 12/22/1999 | EP0964680A1 Use of nitric oxide inhibitors for treating side effects of particulate drugs |
| 12/22/1999 | EP0748228A4 Method and device for the provocation of air passage narrowing and/or the induction of sputum |
| 12/22/1999 | EP0515386B1 Glycoalkaloids |
| 12/21/1999 | US6004555 Methods for the specific coagulation of vasculature |
| 12/21/1999 | US6004554 Methods for targeting the vasculature of solid tumors |
| 12/21/1999 | US6004536 Lipophilic cyanine dyes with enchanced aqueous solubilty |
| 12/21/1999 | US6004533 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 12/21/1999 | US6004529 Chelating agents |
| 12/16/1999 | WO1999064869A2 Back pain diagnosis and apparatus for use therein |
| 12/16/1999 | WO1999064572A2 Poly(adp-ribose) polymerase gene |
| 12/16/1999 | WO1999056790A3 13c glucose breath test for the diagnosis of diabetes |
| 12/16/1999 | WO1999042435A3 Myxochelines |
| 12/15/1999 | EP0963759A1 The use of a vital dye for facilitating surgical procedures for cataract extraction |
| 12/15/1999 | EP0963209A2 Improvements in or relating to diagnostic/therapeutic agents |
| 12/15/1999 | EP0750612B1 Acridone-derived bisintercalators as chemotherapeutic agents |
| 12/15/1999 | CN1238702A Radiolabeled DNA oligonuleotide, method of preparation and therapeutic uses |
| 12/15/1999 | CN1238701A Process for preparing iodinated organic X-ray contrast agents |
| 12/15/1999 | CN1238700A Improvents in or relating to diagnostic/therapeutic agents |
| 12/15/1999 | CN1238699A Improvements in or relating to contrast agents |
| 12/15/1999 | CN1238698A Method |
| 12/14/1999 | US6001605 Dna sequence coding for two cytokines; diagnosing human colon cancer; for detecting antiinflammatory agents |
| 12/14/1999 | US6001583 Contacting cell having complex of shc polypeptide/grb-7 adaptor polypeptide with compound that acts intracellularly to disrupt the complex; for prevention, prognostic evaluation, and treatment of cancer especially breast cancer |
| 12/14/1999 | US6001335 Synthesizing a lipid vesicle having a gas encapsulated therein for ultrasonic imaging, by subjecting a solvent-free composition of a gaseous precursor and lipid in aqueous medium to a first pressure, then a second lower pressure |
| 12/14/1999 | US6001334 Barium powder of large, medium and small particle sizes in specific weight ratios, coated with a composite additive of gum tragacanth and carageenan in specific ratios depending on particle size and surface area; no parasympatholytic agents |
| 12/14/1999 | US6001333 Methods of preparing micro encapsulated agents for use in the detection of tumors by CT imaging |
| 12/14/1999 | US6001332 Medical gas mixture |
| 12/14/1999 | CA2172607C Phorbine derivatives and their use in the diagnosis and therapy of cancer |
| 12/14/1999 | CA2135642C Tat-derived transport polypeptides |
| 12/09/1999 | WO1999063115A2 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 12/09/1999 | WO1999062512A1 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical substances containing the same, method for the production and use thereof in photodynamic therapy and mri diagnosis |
| 12/09/1999 | WO1999046367A3 Methods of diagnosis and triage using cell activation measures |
| 12/09/1999 | WO1998025648A3 Use of a texaphyrin in ocular diagnosis and therapy |
| 12/09/1999 | DE19825512A1 3-,8-subsituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik 3-, 8-subsituierte Deuteroporphyrinderivate, pharmaceutical compositions containing them, processes for their preparation and their use in photodynamic therapy and MRI diagnostics |
| 12/09/1999 | DE19824535A1 Neue Rhodamin-Derivate und deren Verwendung New rhodamine derivatives and their use |
| 12/09/1999 | CA2334117A1 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 12/08/1999 | EP0962497A1 Rhodamine derivates and their use in diagnostic systems |
| 12/08/1999 | EP0961612A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 12/08/1999 | EP0656762B1 Magnetic resonance arteriography with dynamic intravenous contrast agents |
| 12/08/1999 | EP0577675B1 Contrast media |
| 12/08/1999 | CN1237981A Peptide diagnostic and therapeutic agent for autoimmune diseases |
| 12/08/1999 | CN1237911A Optical diagnostic agents for diagnosis of neurodenerative diseases by means of near infra-red radiation (NIR-Radiation) |
| 12/08/1999 | CN1237901A Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof |
| 12/08/1999 | CN1047094C Method for preparing label of colonic transportation test |
| 12/07/1999 | USRE36433 Dissolving in secondary butanol; crystallization |
| 12/07/1999 | US5998603 4'-desmethyl nucleoside analogs, and oligomers thereof |
| 12/07/1999 | US5997904 Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
| 12/07/1999 | US5997898 Stabilized compositions of a sf6 gas and a phosphorylated fluorinated amphiphilic compound, contrast agents for ultrasound. |
| 12/07/1999 | US5997846 Method for detecting arthropods |
| 12/07/1999 | US5997523 Vascular catheter having low-profile distal end |
| 12/02/1999 | WO1999062079A1 Nucleation and growth of magnetic metal oxide nanoparticles and its use |
| 12/02/1999 | WO1999061072A2 Methods of inhibiting clot formation |
| 12/02/1999 | WO1999061070A1 Diagnostic method and diagnostic means used in carrying out said method |
| 12/02/1999 | WO1999061058A1 Method of altering heartbeat |
| 12/02/1999 | WO1999060920A2 Mr signal-emitting coatings |
| 12/02/1999 | CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration |
| 12/01/1999 | EP0959908A1 Novel targeted contrast agents for diagnostic and therapeutic use |
| 12/01/1999 | EP0959907A1 The butyrophilin gene promoter and uses thereof |
| 12/01/1999 | EP0959906A1 Delta 1,6 bicyclo [4,4,0] functional dyes for contrast enhancement in optical imaging |
| 12/01/1999 | EP0783325B1 Contrast agent |
| 11/30/1999 | USRE36418 Contrast media comprising a non-ionic contrast agent with low levels of sodium and calcium ions |
| 11/30/1999 | US5994535 Water soluble texaphyrin metal complex preparation |